Testing a decision-support tool for patients with head and neck cancer
Official title: Feasibility Testing a Decision-support Intervention for Clinical Trials
Run by University of Aarhus · NCT06291610 · Data updated 2026-11-12
This study is testing a new support tool to help patients with head and neck cancer make better choices about joining clinical trials.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University of Aarhus Academic / other |
| Locations | 1 site (Aarhus) |
| Status | Recruiting |
| Started | February 19, 2024 |
| Main results expected | December 31, 2025 |
| Study ends | December 31, 2026 |
| Registry record updated | March 4, 2024 |
| Trial ID | NCT06291610 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old who have been diagnosed with cancer of the pharynx or larynx and can communicate in Danish.
✕Probably not a fit
Patients with dyslexia may not benefit from this study due to potential challenges in understanding the decision aid materials.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study develops and tests a decision-support intervention aimed at helping patients with laryngeal and pharyngeal cancer make informed choices about participating in clinical trials. The intervention includes a tailored patient decision aid, decision coaching consultations with trained healthcare professionals, and a training program for these coaches. The feasibility of this intervention will be assessed by comparing responses from 60 patients before and after engaging with the decision support tools. The primary focus is on enhancing patient involvement in clinical trial decision-making.
Why it matters
Potential benefit: If successful, this intervention could empower patients to make more informed decisions regarding their participation in clinical trials.
How similar studies have gone: While decision-support interventions are emerging, this specific approach tailored for clinical trial participation is relatively novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with cancer of the pharynx or larynx * Received verbal information regarding DAHANCA 35 * Read the patient information folder from DAHANCA 35 * Above 18 years * Danish speaking Exclusion Criteria: * Dyslexia
Where it's running
-
Aarhus University Hospital
Aarhus, Denmark Recruiting
Study contacts
- Principal investigator: Jeppe Friborg, MD, PhD — Copenhagen University Hospital, Rigshospitalet
- Study coordinator: Anne Kristensen, MSc
- Email: annkrs@rm.dk
- Phone: +4530315605
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Longer antibiotic prophylaxis after head and neck cancer surgery
This trial tests whether giving antibiotics for 7 days after major mouth and throat cancer surgery reduces wound infections compared with the standard 24-hour course.
-
Tai Chi during radiotherapy for head and neck cancer fatigue
This trial tests whether a 12-week Yang-style Tai Chi program added to usual care can reduce cancer-related fatigue in adults with head and neck cancer undergoing radiotherapy.
-
Topical Boswellia 2% Cream to Prevent Radiation Dermatitis in Head and Neck Cancer
A topical 2% Boswellia serrata cream is tested to see if it can prevent skin irritation from radiation in people with head and neck cancer.
-
Methylscape test in body fluids for multi-cancer detection in Colombia
A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.
-
Foot reflexology and ta-VNS for symptom relief in head and neck cancer during CCRT
This trial tests whether foot reflexology, transcutaneous auricular vagus nerve stimulation, and auricular acupressure can reduce pain, dry mouth, fatigue, and other symptoms for head and neck cancer patients receiving cisplatin-based chemoradiotherapy.
-
Ozone gas plus biomimetic toothpaste and mouthwash to treat cancer therapy mouth sores
This trial will test whether adding a biomimetic toothpaste and mouthwash to ozone gas therapy helps adults with chemo- or radiotherapy-induced mouth sores heal faster and have less pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.